Challenges in assessing costs of rheumatoid arthritis.
Harrison
Melanie J
MJ
Weil Medical College of Cornell University, New York, NY, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D019090:Case Management / Q000458:organization & administration; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data; D016903:Drug Monitoring / Q000191:economics; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008403:Mass Screening / Q000191:economics; D020380:Needs Assessment / Q000458:organization & administration; D012017:Referral and Consultation / Q000191:economics; D014481:United States / Q000453:epidemiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents